Transient receptor potential vanilloid-1 in epidermal keratinocytes may contribute to acute pain in herpes zoster

Acta Dermato-Venereologica

Volumn 96, Issue 3, 2016, Pages 319-322

  Han, Sang Bum ^a,b,c   Kim, Hyeree ^d   Hyun Cho, Sang ^d   Lee, Jeong Deuk ^d   Chung, Jin Ho ^a,b,c   Kim, Hei Sung ^d  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Seoul National University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Acute pain; Herpes zoster; Transient receptor potential vanilloid 1

Indexed keywords

ANTIVIRUS AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 1BETA; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; TRPV1 PROTEIN, HUMAN; VANILLOID RECEPTOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPIDERMIS CELL; FEMALE; HERPES ZOSTER; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; MALE; PAIN; PRIORITY JOURNAL; SKIN DISEASE; VARICELLA ZOSTER VIRUS; ACUTE PAIN; BIOPSY; CASE CONTROL STUDY; CHEMISTRY; EPIDERMIS; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; MIDDLE AGED; PAIN MEASUREMENT; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ACUTE PAIN; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CASE-CONTROL STUDIES; EPIDERMIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HERPES ZOSTER; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PAIN MEASUREMENT; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; TRPV CATION CHANNELS; YOUNG ADULT;

EID: 84959168990     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-2247     Document Type: Article

References (30)

1. Kinchington PR, Goins WF. Varicella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models. J Neurovirol 2011; 17: 590-599.
2. Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain 2002; 18: S177-181.
3. Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ. Review: the neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol 2011; 37: 441-463.
4. Hempenstall K, Nurmikko TJ, Johnson RW, A’Hern RP, Rice AS. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2005; 2: e164.
5. Weinberg JM. Herpes zoster: epidemiology, natural history, and common complications. J Am Acad Dermatol 2007; 57: S130-135.
6. Kurokawa I, Yamamoto M, Kurata T. Varicella zoster virus antigens in the epidermis of patients with herpes zoster before and after treatment with acyclovir: an immunohistochemical study. J Int Med Res 2001; 29: 198-203.
7. Sulk M, Seeliger S, Aubert J, Schwab VD, Cevikbas F, Rivier M, et al. Distribution and expression of non-neuronal transient receptor potential ion channels in rosacea. J Invest Dermatol 2012; 132: 1253-1262.
8. Bevan S, Andersson DA. TRP channel antagonists for painopportunities beyond TRPV1. Curr Opin Investig Drugs 2009; 10: 655-663.
9. Fernandes ES, Russell FA, Spina D, McDougall JJ, Graepel R, Gentry C, et al. A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund’s complete adjuvant-induced monoarthritis. Arthritis Rheum 2011; 63: 819-829.
10. Geppetti P, Nassini R, Materazzi S, Benemei S. The concept of neurogenic inflammation. BJU Int 2008; 101: 2-6.
11. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
12. Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain 2005; 6: 149-158.
13. Asada H, Nagayama K, Okazaki A, Mori Y, Okuno Y, Takao Y, et al. An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain. J Dermatol Sci 2013; 69: 243-249.
14. Kassis V, Sondergaard J. Heat separation of normal human skin for epidermal and dermal prostaglandin analysis. Arch Dermatol Res 1982; 273: 301-306.
15. Frenandes ES, Fernandes MA, Keeble JE. The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 2012; 166: 510-521.
16. Bodo E, Kovacs I, Telek A, Varga A, Paus R, Kovacs L, et al. Vanilloid receptor-1 (VR1) is widely expressed on various epithelial and mesenchymal cell types of human skin. J Invest Dermatol 2004; 123: 410-413.
17. Kim SJ, Lee SA, Yun SJ, Kim JK, Park JS, Jeong HS, et al. Expression of vanilloid receptor 1 in cultured fibroblasts. Exp Dermatol 2006; 15: 362-367.
18. Stander S, Moormann C, Schumacher M, Buddenkotte J, Artuc M, Shpacovitch V, et al. Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol 2004; 13: 129-139.
19. Aubdool AA, Brian SD. Neurovascular aspects of skin neurogenic inflammation. J Investig Dermatol Symp Proc 2011; 15: 33-39.
20. Dworkin RH, Perkins FM, Nagasako EM. Prospects for the prevention of postherpetic neuralgia in herpes zoster patients. Clin J Pain 2000; 16: S90-100.
21. Costigan M, Woolf CJ. Pain molecular mechanisms. J Pain 2000; 1: 35-44.
22. Grone A, Fonfara S, Baumgartner W. Cell type-dependent cytokine expression after canine distemper virus infection. Viral Immunol 2002; 15: 493-505.
23. Southall MD, Li T, Gharibova LS, Pei Y, Nicol GD, Travers JB. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J Pharmacol Exp Ther 2003; 304: 217-222.
24. Atoyan R, Shander D, Botchkareva NV. Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin. J Invest Dermatol 2009; 129: 2312-2315.
25. Schaible HG, Schmidt RF. Excitation and sensitization of fine articular afferents from cat’s knee joint by prostaglandin E2. J Physiol 1988; 403: 91-104.
26. Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, et al. Nociceptors are interleukin-1beta sensors. J Neurosci 2008; 28: 14062-14073.
27. Pavan-Langston D. Herpes zoster antivirals and pain management. Ophthalmology 2008; 115: S13-20.
28. Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, et al. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Molecular Pain 2005; 1: 3.
29. Rose TM, Reilly CA, Deering-Rice CE, Brewster C, Brewster C. Inhibition of FAAH, TRPV1, and COX2 by NSAID-serotonin conjugates. Bioorg Med Chem Lett 2014; 24: 5695-5698.
30. Maurer K, Binzen U, Morz H, Bugert P, Schedel A, Treede RD, et al. Acetylsalicylic acid enhances tachyphylaxis of repetitive capsaicin responses in TRPV1-GFP expressing HEK293 cells. Neurosci Lett 2014; 563: 101-106.